Sotera Health Company revised earnings guidance for the year 2023. For the year, the company expects results will be at the lower end of its previously announced outlook of net revenues to be in the range of $1.035 billion to $1.055 billion, representing growth of approximately 3% to 5%, compared to the prior year.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11 USD | -2.35% | -2.34% | -34.39% |
05:59pm | Sotera Health Shares Fall After Q1 Results, Outlook Reaffirmed | MT |
03:00pm | Transcript : Sotera Health Company, Q1 2024 Earnings Call, May 02, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.39% | 3.19B | |
+14.24% | 81.84B | |
-30.27% | 70.69B | |
+9.37% | 29.03B | |
-11.90% | 16.97B | |
-0.36% | 16.83B | |
-1.17% | 15.28B | |
+5.90% | 12.41B | |
+36.47% | 12.26B | |
-4.20% | 11.86B |
- Stock Market
- Equities
- SHC Stock
- News Sotera Health Company
- Sotera Health Company Revises Earnings Guidance for the Year 2023